These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2547663

  • 21. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 22. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
    Ferguson MK, Little AG, Golomb HM, Hoffman PC, DeMeester TR, Beveridge R, Skinner DB.
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 25. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
    McCaughan BC, Martini N, Bains MS, McCormack PM.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
    [Abstract] [Full Text] [Related]

  • 26. Multimodality therapy including surgical resection for limited small cell lung cancer.
    Chen X, Li S, Zuo D, Liu S, Bai L, Yian D, Huang Z.
    Chin Med J (Engl); 1995 Sep; 108(9):689-91. PubMed ID: 8575236
    [Abstract] [Full Text] [Related]

  • 27. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D, Stamatis G.
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Multimodal treatment of non small cell lung cancer].
    Stoelben E, Digel W, Henke M, Passlick B.
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [Abstract] [Full Text] [Related]

  • 30. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group.
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [Abstract] [Full Text] [Related]

  • 31. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.
    Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542
    [Abstract] [Full Text] [Related]

  • 32. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Nov 01; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 33. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033
    [Abstract] [Full Text] [Related]

  • 34. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C.
    Ann Thorac Surg; 2005 Jan 20; 79(1):225-33. PubMed ID: 15620948
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
    Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD.
    J Clin Oncol; 2006 Jul 01; 24(19):2998-3006. PubMed ID: 16769986
    [Abstract] [Full Text] [Related]

  • 37. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
    Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S.
    J Thorac Cardiovasc Surg; 2007 Jul 01; 134(1):188-93. PubMed ID: 17599507
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan 01; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 39. The role of surgery in the combined management of small cell bronchial carcinoma.
    Salzer GM, Müller LC, Frommhold H, Huber H, Lechleitner M.
    Thorac Cardiovasc Surg; 1986 Oct 01; 34(5):326-9. PubMed ID: 2431506
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.